On Monday, Shares of The Dow Chemical Company (NYSE:DOW), lost -1.60% to $43.08.
Dow AgroSciences, a wholly owned partner of The Dow Chemical Company and Critical Path Services declared a license agreement granting Critical Path Services a non-exclusive license to Dow AgroSciences’ patented (U.S. 8,227,252) intellectual property that comprises a high throughput method for detecting multiple proteins in plants using mass spectroscopy.
As agricultural innovation continues to accelerate around the world, there is a growing need among both agricultural companies, contract research organizations, public research organizations, and government regulators to more efficiently identify proteins in plant samples both naturally occurring and from trait introgression.
To meet the growing need, Dow AgroSciences has invented a more efficient, high throughput method using liquid chromatography with tandem mass spectroscopy (LC/MS/MS) to multiplex the measurement of increasing numbers of proteins in plants of interest to companies and government regulators. This cutting-edge technology referred to as Plextein™, is being licensed to Critical Path Services in a non-exclusive agreement.
“Plextein has the potential to accelerate the discovery and development of novel plant traits by simplifying the analysis of complex samples which ultimately benefits farmers with new products,” said Tom Meade, Dow AgroSciences Global Seeds Discovery Leader. “Our intent to broadly license this high throughput solution reflects our commitment to sharing the benefits of our innovation with third parties, counting contract research and service companies such as Critical Path Services.”
“LC/MS/MS is a very powerful tool for protein quantitation in situations where an ELISA approach is not viable,” stated Julie Eble, President and CEO of Critical Path Services. “With access to Dow AgroSciences’ Plextein technology, we can address multiple proteins in a single run for clients facing this common situation. We expect this will move the science and the products of agricultural biotechnology ahead more quickly in addition to more efficiently.”
The Dow Chemical Company manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide. It operates through Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals, and Performance Plastics segments.
Shares of The Walt Disney Company (NYSE:DIS), declined -0.63% to $103.82, during its last trading session.
SQUARE ENIX® and Disney Interactive revealed that development has begun on KINGDOM HEARTS HD 2.8 Final Chapter Prologue, a compilation that brings the popular KINGDOM HEARTS [Dream Drop Distance] to the PlayStation®4 computer entertainment system platform remastered in high definition.
Originally released in 2012, KINGDOM HEARTS [Dream Drop Distance] HD is a full-HD remastered version of KINGDOM HEARTS 3D [Dream Drop Distance]. Series protagonists Sora and Riku take on the Mark of Mastery exam in preparation for coming threats. The signature action of the KINGDOM HEARTS series has evolved, allowing players to experience faster-paced battles and exploration at a blistering pace.
This newly remastered title also features:
KINGDOM HEARTS 0.2 Birth by Sleep – A Fragmentary Passage –
A completely new playable episode that links to the story of KINGDOM HEARTS III, taking place after the storyline of KINGDOM HEARTS Birth by Sleep played from the perspective of Aqua.
KINGDOM HEARTS χ[chi] Back Cover (movie)
A new HD movie that tells the mysterious story of the Foretellers, connecting the earliest parts of the series’ history, showcased in the forthcoming mobile title KINGDOM HEARTS Unchained χ[chi].
The Walt Disney Company, together with its auxiliaries, operates as an entertainment company worldwide. The company operates in five segments: Media Networks, Parks and Resorts, Studio Entertainment, Consumer Products, and Interactive.
Shares of Mylan N.V. (NASDAQ:MYL), inclined 0.84% to $49.06, during its last trading session.
Mylan N.V., declared that the Company will present at the Morgan Stanley Global Healthcare Conference on Thursday, Sept. 17, 2015. The presentation is planned to start at 4:40 p.m. ET.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
Finally, Hovnanian Enterprises Inc. (NYSE:HOV), ended its last trade with -1.97% loss, and closed at $1.99.
Hovnanian Enterprises, stated results for its fiscal third quarter and nine months ended July 31, 2015.
RESULTS FOR THE THREE AND NINE MONTH PERIODS ENDED JULY 31, 2015:
- Total revenues were $540.6 million in the third quarter of fiscal 2015, a decrease of 1.9% contrast with $551.0 million in the third quarter of fiscal 2014. For the nine months ended July 31, 2015, total revenues raised 7.4% to $1.46 billion contrast with $1.36 billion in the first nine months of the prior year.
- Homebuilding gross margin percentage, before interest expense and land charges comprised in cost of sales, was 17.8% for the third quarter ended July 31, 2015, contrast with 21.3% in last year’s third quarter, and was 16.1% for the second quarter of fiscal 2015. During the first nine months of fiscal 2015, homebuilding gross margin percentage, before interest expense and land charges comprised in cost of sales, was 17.4% contrast with 20.2% in the same period of the previous year.
- Net loss was $7.7 million, or $0.05 per common share, for the third quarter of fiscal 2015, contrast with net income $17.1 million, or $0.11 per common share, in the third quarter of the previous year. For the nine months ended July 31, 2015, the net loss was $41.6 million, or $0.28 per common share, contrast with a net loss of $15.3 million, or $0.10 per common share, in the first nine months of fiscal 2014.
- The pre-tax loss, not taking into account land-related charges and loss on extinguishment of debt, in the third quarter of fiscal 2015 was $8.9 million contrast with net income of $16.1 million in the prior year’s third quarter. For the first nine months of fiscal 2015, the pre-tax loss, not taking into account land-related charges and loss on extinguishment of debt, was $51.5 million contrast with a loss of $12.7 million during the first nine months of fiscal 2014.
- The dollar value of merged net contracts raised 19.7% to $619.4 million for the three months ended July 31, 2015 contrast with $517.3 million during the same quarter a year ago. The dollar value of net contracts, counting unmerged joint ventures, during the third quarter of fiscal 2015 raised 27.9% to $694.6 million contrast with $542.9 million in last year’s third quarter.
- In the third quarter of fiscal 2015, the number of merged net contracts raised 13.0% to 1,533 homes contrast with 1,357 homes in the prior year’s third quarter. The number of net contracts, counting unmerged joint ventures, raised 16.4% to 1,658 homes for the third quarter of fiscal 2015 from 1,424 homes during the third quarter of fiscal 2014.
- The dollar value of merged net contracts raised 14.3% to $1.82 billion for the first nine months of fiscal 2015 contrast with $1.59 billion in the first nine months of the previous year. The dollar value of net contracts, counting unmerged joint ventures, for the nine months ended July 31, 2015 raised 15.6% to $1.97 billion contrast with $1.70 billion in the first nine months of fiscal 2014.
- For the nine months ended July 31, 2015, the number of merged net contracts raised 9.2% to 4,648 homes contrast with 4,258 homes in the first nine months of the prior year. The number of net contracts, counting unmerged joint ventures, raised 8.5% to 4,918 homes for the nine months ended July 31, 2015 from 4,533 homes in the first nine months of last year.
Hovnanian Enterprises, Inc. designs, constructs, markets, and sells residential homes in the United States. It constructs single-family detached homes, attached townhomes and condominiums, urban infill, and active adult homes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
